373 Followers on Owler

Nurix

is a California-based biotechnology company that researches and develops small-molecule therapies for the treatment of cancer and immune disorders... Read more
OverviewCompetitorsFundingNews & Insights

Nurix

is a California-based biotechnology company that researches and develops small-molecule therapies for the treatment of cancer and immune disorders... Read more
Nurix President & CEO: Arthur T. Sands

President & CEO

Arthur T. Sands

CEO Approval Rating

91/100

2009

PublicNASDAQNRIX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$65.5M
Employees
300
Funding
$983.6M

News

Funding
Oct 27, 2025
GlobalNewswire
Nurix received $250M in Post-IPO Equity Funding
Partnership
Sep 17, 2025
centralcharts
Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis

Nurix Competitors

1Kymera
2Arvinas
3BioTheryX
4Cedilla
5Plexium
6Cullgen
7Kronos Bio
8Progenra
9Cantex Pharmaceuticals, Inc.
Unlock 6 + competitors

Trending Companies